1065 / 1708
Anaplastic Wilms’ Tumor
•
In NWTS-4, Stage I AH pts were treated with AMD
and VCR and had 2-yr overall survival estimates of
85.5% to 93.3% depending on AMD administration
regimen
•
Stage II to IV AH pts were treated with AMD, VCR
and DOX and had 4-yr overall survival rate of 27.1%
without CPM and 52.2% with CPM (p = 0.04)